# Study of COVID-19 DNA Vaccine (AG0302-COVID19)

> **NCT04527081** · PHASE1,PHASE2 · COMPLETED · sponsor: **AnGes, Inc.** · enrollment: 30 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** AG0302-COVID19
- **BIOLOGICAL:** AG0302-COVID19
- **BIOLOGICAL:** AG0302-COVID19

## Key facts

- **NCT ID:** NCT04527081
- **Lead sponsor:** AnGes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-31
- **Primary completion:** 2020-11-09
- **Final completion:** 2021-09-24
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04527081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04527081, "Study of COVID-19 DNA Vaccine (AG0302-COVID19)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04527081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*